DNAtrix Announces Oral Presentation of Positive Overall Survival Data With DNX-2401 in DIPG at the Society for Neuro-Oncology (SNO) Annual Meeting
UF startup DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, announced that data from the Phase 1 study of DNX-2401 in diffuse intrinsic pontine glioma (DIPG) was presented in an oral presentation at the 26th Annual Meeting and Education Day of the Society for Neuro-oncology (SNO), which was held from November 18-21, 2021 in Boston, MA.
Lacerta Therapeutics Appoints Min Wang, PhD, JD and Marc Wolff to Its Board of Directors
UF startup and UF Innovate | Accelerate at Sid Martin Biotech graduate Lacerta Therapeutics, Inc., a gene therapy company dedicated to the discovery and development of AAV-based gene therapies, appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors.
University of Florida Citrus Faculty Secure Federal Funding in Ongoing Fight Against Citrus Greening
University of Florida citrus researchers continue to provide innovative leadership in the fight against the devastating disease Huanglongbing, also known as citrus greening disease.
Two Common Compounds Show Effectiveness Against COVID-19 Virus in Early Testing
A pair of over-the-counter compounds has been found in preliminary tests to inhibit the virus that causes COVID-19, University of Florida Health researchers have found.
UF’s COVID Restore Clinic Treats Long Haulers
Dr. Irene Estores, medical director of the Integrative Medicine Program at UF leads the COVID Restore Clinic to treat long haulers. According to the WHO definition, long COVID “occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis.”
Lauren and Lee Fixel Foundation Establish the Fixel Brain Mapping Professorship
Aysegul Gunduz, Ph.D., an associate professor in University of Florida’s J. Crayton Pruitt Family Department of Biomedical Engineering, was named the inaugural Fixel Brain Mapping Professor.
Researchers Receive $1.2M NSF Grant To Study and Thwart Surveillanceware
Using a new $1.2 million grant from the National Science Foundation researchers at the University of Florida will study surveillanceware and develop new AI-based defenses for it.
UF Neuroscientist Featured in Society for Neuroscience Annual Report
Research by Adam J. Woods, Ph.D., associate director of UF’s Center for Cognitive Aging and Memory, and collaborators using artificial intelligence to personalize transcranial direct current stimulation (tDCS) was highlighted in the Society for Neuroscience’s 2021 annual report.
Host Immunity Drives Viral Evolution of Dengue
New research by a team of University of Florida investigators, and others, provides evidence that host immunity drives the evolution of the dengue virus.
Talking About Feeling: Axogen Raises Awareness for Mastectomy Side Effect
In the wake of Breast Cancer Awareness Month, UF startup and UF Innovate | Accelerate at Sid Martin Biotech graduate Axogen has expanded the scope of a campaign to raise awareness about a side effect of mastectomies.
